We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Azenta Inc (AZTA) USD0.01

Sell:$70.85 Buy:$70.87 Change: $1.23 (1.71%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $1.23 (1.71%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $1.23 (1.71%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Azenta, Inc. (Azenta), formerly Brooks Automation, Inc., is a provider of life sciences solutions worldwide, enabling therapies to market faster. Azenta provides a full suite of cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's services include genomics services, sample and management solutions, sample and material storage, clinical trial management, drug products and cell therapies, sample prep and lab services, lab moving and biological transport, information technology solutions, and business continuity and risk mitigation. Azenta has operations in North America, Europe and Asia.

Contact details

15 Elizabeth Dr
United States
+1 (978) 2622400

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$5.37 billion
Shares in issue:
74.99 million
Life Sciences Tools & Services
United States
US dollar

Key personnel

  • Stephen Schwartz
    President, Chief Executive Officer, Director
  • Lindon Robertson
    Chief Financial Officer, Executive Vice President
  • Matthew McManus
    Chief Operating Officer
  • Kimberly Crowley
    Chief Human Resource Officer, Senior Vice President
  • Jason Joseph
    Senior Vice President, General Counsel, Secretary
  • Robin Vacha
    Senior Vice President and General Manager, Life Sciences Products
  • William Montone
    Senior Vice President - Human Resources
  • Linda De Jesus
    Senior Vice President and Chief Commercial Officer, Azenta Life Sciences
  • David Gray
    Senior Vice President, Chief Strategy and New Business Officer
  • Vandana Sriram
    Vice President - Finance, and Corporate Controller, Principal Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.